HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

International Summit on Hematology and Blood Disorders

April 27-29, 2023 | Orlando, USA

April 27 -29, 2023 | Orlando, Florida, USA

About Hematology 2023 | Hybrid Event

Magnus Group is pleased to welcome you to join the forthcoming International Summit on Hematology and Blood Disorders” (Hematology 2023).

We are delighted to provide both in-person and virtual attendance options for this congress. The hybrid experience will allow attendees to attend sessions in Orlando, Florida, USA or Virtually from home or work during  April 27-29, 2023. Regardless of which option is selected, we are committed to offering a world-class meeting experience.

The conference deliberations will be on the theme “Transfusing Innovations and Exploring Emerging Concepts in Hematologyand it amalgamates researchers, scientists, academicians, healthcare professionals, haematologists, transfusion experts, physicians, nurses, practitioners, clinicians, industry representatives and individuals who are fascinated in sharing their plethora of knowledge and research in all aspects related to haematology and blood disorders whilst highlighting the best practices from different verticals in this field.

The congress will be structured around a series of keynotes sessions, symposiums, workshops, oral and poster presentations in which delegates will have the opportunity to network with and learn from leaders in the academic and corporate medical imaging and clinical research communities throughout the world. The scientific gathering provides an incredible opportunity to a vast array of individuals from the Hematology community to combat the concerns that surround the blood disorders.

Hematological abnormalities are thought to play a role in COVID-19 disease progression. However, the precise relationships between certain blood markers and COVID-19 are unknown. The conference also aims to assess if there are any links between haematological markers and the severity of COVID-19.

We are anticipating a highly thriving and open community in which you will join us and find Hematology 2023 quite engaging and promising for future developments.

Recommended: Hematology Conferences 2023 | Blood Disorders Conference 2023 | Hematology Conferences | Blood Disorders Events 2023 | Blood Diseases Congress | Hematology Meetings

SIGN UP FOR UPDATES

Get news, updates, and more from the Conference.

Antispam Code Generate new code

By submitting this form, you are consenting to receive emails and notifications from Magnus Group. You can revoke your consent to receive emails at any time by using the Safe Unsubscribe link, found at the bottom of every email.

Speakers

Sanghoon Lee, Speaker at Blood Diseases Congress

Sanghoon Lee

Marshall University, United States
Brandon Lucke Wold, Speaker at Hematology Meetings

Brandon Lucke Wold

University of Florida, United States
Erin Weigel, Speaker at Hematology Conferences

Erin Weigel

Kedrion Biopharma, United States
Melika Loriamini, Speaker at Hematology Conferences

Melika Loriamini

University of Toronto, Canada
Priyal Shah, Speaker at Blood Disorders Events

Priyal Shah

University of Toronto, Canada
Jean Mercier Ythier, Speaker at Hematology Meetings

Jean Mercier Ythier

University of Paris-Panthéon-Assas, France

Media Partner

Conference Alert
Events get
Industry Events
Clocate

Past Conference Information

Upcoming Hematology Conferences: 

Conference Venue Dates
International Summit on Hematology and Blood Disorders Orlando, USA

April 27-29, 2023

3rd Edition of Global Conference on Pharmaceutics and Drug Delivery Systems (PDDS 2019) Report:

Magnus Group successfully completed 3rd Edition of Global Conference on Pharmaceutics and Drug Delivery Systems (PDDS 2019) at Paris, France during June 24-26, 2019.

Day 1:  June 24, 2019 (Monday)

The conference was initiated by Moderator Fabien Gosselet from Blood-brain barrier laboratory, Artois University, France with the Honourable presence of the Keynote forum. The list includes:

Vladimir P. Torchilin, Northeastern University, USA
Robert Houlden, Formulytica Pty. Ltd, Australia
Robert P. Bianchi, Prescription Drug Research Center, USA
Georgina Kate Such, University of Melbourne, Australia

Recommended Hematology Conferences | Blood Disorders Conference | Hematology Conferences | Blood Disorders Events | Blood Diseases Congress | Hematology Meetings | Hematology Congresses | Hematology Events | Hematology Conferences 2023 | Blood Disorders Conference 2023 | Hematology Congresses 2023 | Hematology Meetings 2023 | Blood Disorders Congress 2023 | Blood Disorders Events | Hematology Meeting | Hematology Conference | Hematology Meeting 2023

Oral Presentations were held on Novel Developments In Drug Delivery System, Formulation Technologies, Advanced Drug Delivery Systems, Drug Delivery Through BBB, Biodrugs, Biomolecules and Therapeutics Session under the guidance of Session chairs. 

Day 1 Speakers with their Presentation Details:

Title: Docetaxel-liposomes prepared by the dual centrifugation method: Effect of propylene glycol and lipid charge on liposomal characteristics

Ann Mari Holsæter, The Arctic University of Norway, Norway

Title: Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments
Jan Tavernier, UGent/VIB, Belgium

Title: Lipid and carbohydrate based delivery vesicles for gene therapeutics: Approaching difficult diseases
Kira Astakhova, Technical University of Denmark, Denmark

Title: In vitro modeling of the blood-brain barrier to assess CNS drug delivery
Fabien Gosselet, Blood-brain barrier laboratory, Artois University, France

Title: Prototyping and evaluating a novel humanoid chewing robot for drug delivery using a medicated chewing gum
Kazem Alemzadeh, University of Bristol, UK

Title: Multifunctionalized and targeted biocatalytic nanoreactor for combinatory treatment of ER+ breast cancer
Rafael Vazquez-Duhalt, Universidad Nacional Autónoma de México, Mexico

Title: New approach to study difference in NSAIDs enantiomer activity, including chiral inversion
Tatyana Viktorovna Leshina, Voevodsky Institute of Chemical Kinetics and Combustion of Russian Academy of Science, Russia

Title: In situ delivery and production system of anti-cancer molecules with gene-engineered
Shun’ichiro Taniguchi, Shinshu University School of Medicine, Japan

Title: Influence of mucoadhesivity on the bioavailability of nanoparticulate drug delivery systems
Ylenia Zambito, University of Pisa, Italy

Title: Systemic liver-targeting delivery of a novel DNA/RNA heteroduplex oligonucleotide via an enteral route
Chie Watanabe, Josai University, Japan

Title: Physicochemical and biophysical study of mechanisms the drugs bioavailability enhancement with new multifunctional delivery systems
Nikolay E. Polyakov, Voevodsky Institute of Chemical Kinetics and Combustion of Russian Academy of Science, Russia

Title: Designing ADME formulations with matching exposures to amorphous solid dosage forms
Aditya Tatavarti, Merck Sharp & Dohme Inc, USA 

Title: Wound healing mats made of layer by layer coated nanoparticles and electrospun nanofibers
Gulcin Arslan Azizoglu, Ege University, Turkey

Title: In vitro model of diclofenac sodium gel delivery through pig skin
Enkelejda Goci, Aldent University, Albania

Title: Influence of formulation and freeze drying process variations on protein stability
Paritosh Pande, IMA Life North America and University of Connecticut, USA

Title: Valproic acid encapsulated biodegradable microneedles for treatment of androgenetic alopecia
Shayan Fakhraei Lahiji, Yonsei University, South Korea

Title: Therapeutic effects of trehalose liposomes against tumors along with apoptosis
Yoko Matsumoto, Sojo University, Japan

Day 2: June 25, 2019 (Tuesday)

Day 2 was initiated by Moderator: Elinaz Farokhi from San Diego State University, USA and the Keynote Forum included:

Mino R. Caira from University of Cape Town, South Africa
Angelita Rebollo from CIMI Paris, France
Rui Tamura from Kyoto University, Japan

Oral Presentations were held on Nanotechnology in Pharmaceutics and Drug delivery systems, Pharmacovigilance and Drug Safety, Therapeutic Drug Carrier Systems, Cellular Targeting and Intracellular Delivery, Pharmaceutical Microbiology and Biotechnology, Vaccine design and drug delivery technology

Day 2 Speakers with their Presentation Details:

Title: Nano- versus micro-particles for S-nitrosoglutathione formulation
Marianne Parent, Université de Lorraine, France

Title: Pseudomonas aeruginosa type 3 secretion system mediated antigen delivery for cancer immunotherapy
Toussaint Bertrand, University Grenoble Alpes, France

Title: Engineering novel selectivity into metalloantibodies germline-encoded precursor to the murine anti-S1P metalloantibody in E.coli and baculovirus-insect cell system
Elinaz Farokhi, San Diego State University, USA

Title: Discovery of novel bacterial genes encoding the enzymes acting on modified uracil/uridine derivatives and their use for gene therapy in cancer treatment
Jaunius Urbonavi?ius, Vilnius Gediminas Technical University, Lithuania

Title: Drug delivery to the skin: Nanostructures for the treatment of precancerous actinic keratosis
Silvia Tampucci, University of Pisa, Italy

Title: Liposomes as valuable drug delivery systems for siRNA and Hsp90 inhibitors to target triple negative breast tumors
Juliette Vergnaud-Gauduchon, Université Paris-Sud, France

Title: A RNA producing DNA hydrogel as a platform for a high performance RNA interference system
Nokyoung Park, Myongji University, South Korea

Title: Metal-organic framework nanoparticles preparation of sildenafil: A new window in the treatment of pulmonary arterial hypertension
Haissam Abou Saleh, Qatar University, Qatar

Title: Release and activity of the broad spectrum antibiotic Rifampicin from biodegradable polymer PLGA
Justine Fraser, The University of Strathclyde, UK

Title: Role of the optimal dynamic state and stabilized catalytic complex for rational design of pharmaceutical enzymes: Engineering of streptokinase with enhanced, fibrin-dependent activity
Farzin Roohvand, Pasteur Institute of Iran, Iran

Title: Pharmacovigilance: Aims, challenges and perspective
Razan Ghattas Mhanna, Lebanese International University, Lebanon

Title: Original Synthesis of natural acetogenins, fattyacids and lembehynes as a potential drugs for treatment of cancer and neurodegenerative diseases
Vladimir A. D’yakonov, Institute of Petrochemistry and Catalysis of RAS, Russia

Title: The nuclear membrane as a barrier to the action of anthracycline chemotherapeutics
Gulnihal Ozcan, Koc University Research Center for Translational Medicine, Turkey

Title: Global legal tools for pharmacovigilance and risk control
Eliana Silva De Moraes, Partner at Silva de Moraes Associes, France and Brazil

Title: Self-propelled objects with high autonomy for transportation
Satoshi Nakata, Hiroshima University, Japan

Poster Presenters with their Presentation Details:

Title: HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors
Mamuka Kvaratskhelia, University of Colorado School of Medicine, USA

Title: Study of the capability of Chitosan-Glutathione nanoparticles to modulate redox state in human Chondrocytes
Roberto Diaz-Torres, National University of Mexico, Mexico

Title: The biomedical application of biogenic silver nanoparticles produced from Cotyledon orbiculata
Samantha Meyer, Cape Peninsula University of Technology, South Africa

Title: Nano-amorphous abiraterone acetate formulation with improved bioavailability and eliminated food effect
Tamás Jordán, NanGenex Inc, Hungary

Title: Dissolution study of drug release from biopolymer matrix tablets
Kevin Matzick, University of Pardubice, Czech Republic

Title: TAA-induced liver damage in KLF10 knockout mice
Azra Memon, Inha University, Republic of Korea

Title: Neuropeptide Y-based recombinant peptides improve bone loss in mice by regulating hematopoietic stem/progenitor cell mobilization
Hee Kyung Jin, Kyungpook National University, Republic of Korea

Title: Antitumor effects of retargeted AAV2 virus on ovarian cancer in vivo
Hyung Jun Ahn, Korea Institute of Science and Technology, South Korea

Title: Niosomal encapsulation of Curcumin: Characterization and its potential as a therapeutic intervention in asthma
Dinesh Kumar Chellappan, International Medical University, Malaysia

Title: Calotropis gigantea extract induces apoptosis through extrinsic/intrinsic pathways and reactive oxygen species generation in A549 and NCI-H1299 non-small cell lung cancer cells
Jiyon Lee, Konkuk University, Republic of Korea

Title: Kinetics of pentoxifylline release from hydrophilic, lipophilic and dual matrix tablets
Barbora Slezáková, University of Pardubice, Czech Republic

Title: Development of rotigotine nanoparticles and its effect on haloperidol induced Parkinsonian symptoms in rats
Subrat Kumar Bhattamisra, International Medical University, Malaysia

Title: Synthesis, evaluation and computational simulation of novel coumarin derivatives as potential acetylcholinesterase inhibitors
Haeil Park, Kangwon National University, Republic of Korea

Title: Characterization and validation of tumor cell-selective penetrating peptides
Angelita Rebollo, CIMI Paris, France

Title: Freshwater sapropel extract for use in medicine and pharmaceutics
Aneka Klavina, Rigas Stradi?š University, Latvia

Title: Fabrication and characterization of transdermal patch loaded with Ascorbic acid
Ahlam Zaid Alkilani, Zarqa University, Jordan

Title: Nanoemulsion–laden organogels of lidocaine as lipid–based systems for topical delivery
Rania Hamed, Al-Zaytoonah University of Jordan, Jordan

Title: Anti-cancer effect of Tuberatolide B in MDA-MB-231 cells through induction of ROS and inhibition of STAT3 pathway
Areumi Park, Korea Institute of Ocean science & Technology, Republic of Korea

Title: Protective effect of Bis (3-bromo-4,5-dihydroxybenzyl) ether against LPS-induced inflammatory response in RAW 264.7 macrophages through ROS-mediated ERK signaling pathway
Soo-Jin Heo, Korea Institute of Ocean science & Technology, Republic of Korea

Title: Saringosterol acetate suppressed hepatocelluar carcinoma growth and metastasis in a zebrafish xenograft model
Eun-A Kim, Korea Institute of Ocean science & Technology, Republic of Korea

Title: Molecular weight characterization of sodium carboxymethyl cellulose by advance polymer chromatography
Ekaterina Sobich, AbbVie Deutschland GmbH & Co. KG R&D, Germany

Title: Strategies to increase the passage of large molecules through the blood brain barrier
Charlotte Lombardi, Grenoble-Alpes University, France

Title: Peptide functionalized nanoparticles for the selective induction of apoptosis in target cells
Mervin Meyer, University of the Western Cape, South Africa

Title: Cell-free expression of a membrane antigen for vaccine uses
Geraldine Mayeux, University Grenoble Alpes, France

Title: Thermoresponsive in situ gelling systems for ophthalmic drug delivery
Concepción Renedo Laguna, University of Seville, Spain 

Recommended Hematology Conferences | Blood Disorders Conference | Hematology Conferences | Blood Disorders Events | Blood Diseases Congress | Hematology Meetings | Hematology Congresses | Hematology Events | Hematology Conferences 2023 | Blood Disorders Conference 2023 | Hematology Congresses 2023 | Hematology Meetings 2023 | Blood Disorders Congress 2023 | Blood Disorders Events | Hematology Meeting | Hematology Conference | Hematology Meeting 2023

Best poster awards was received by:

Rania Hamed, Al-Zaytoonah University of Jordan, Jordan
Mervin Meyer, University of the Western Cape, South Africa

Day 3: June 26, 2019 (Wednesday)

Moderator: Maria van Dongen from The Janssen Pharmaceutical Companies of Johnson & Johnson, Belgium has initiated the keynote session which included:

Ülo Langel from Stockholm University, Sweden
El Hassane Larhrib from University of Huddersfield, UK
Marlene Lúcio from  CF-UM-UP, Portugal
Amanda Silva Brun from CNRS, Université Paris-Diderot, France

Day 3 Speakers with their Presentation Details:

Title: Antibody-guided discovery of potent small-molecule fusion inhibitors of influenza virus
Maria van Dongen, The Janssen Pharmaceutical Companies of Johnson & Johnson, Belgium

Title: Targeting liver function to circumvent neuronal and cardiac dysfunctions linked to hyperhomocysteinemia
Nathalie Janel, University Paris Diderot, France

Title: Detection of “Hidden” drug resistance by the EZMTT assay
Benfang (Bennie) H. Ruan, Zhejiang University of Technology, China

Title: New indications for FDA-approved drugs: Selective inhibition of the growth of Helicobacter pylori by covalent allosteric regulation of urease
Fang Wu, Shanghai Jiao Tong University, China

Title: Chimeric antigen receptor(CAR)-T CELL; a biodrug as cancer therapeutic agent
Preeti Sharma, Satosh Medical College and Hospital, India

Title: Freshwater Sapropel as raw material in medicine and pharmaceutical production
Agris Auce, Rigas Stradins University, Latvia

Title: P-selectin targeted nanocarriers are efficient drug delivery systems to activated endothelium
Manuela Calin, Institute of Cellular Biology and Pathology “N. Simionescu”, Romania

Title: Development of novel leads for triple-negative breast cancer immunotherapy
Jing Yu, Shanghai Jiao Tong University, China

Title: Novel small molecules for PPARs modulation and their potential use for treatment of metabolic disorders
Antonio Laghezza, Università degli Studi di Bari “Aldo Moro”, Italy

Title: Caloric restriction and longevity
Bartolome Ribas Ozonas, Royal National Academy of Pharmacy, Institute of Spain. Madrid, Spain

Title: Synactix Inc and academic case studies of targeted therapy
Hong-yu Li, University of Arkansas for Medical Sciences, USA

Title: Liposomal encapsulation of silver nanoparticles suppresses nanoparticle-induced ROS and inflammation, and induces caspase-dependent apoptosis
Azeez Yusuf, Technical University Dublin, Ireland

Title: Development of substances with biological and pharmacological activity based on structural nucleus hybrids from phytochemical compounds like secondary metabolites
José Eduardo Cuéllar, Universidad Nacional de Colombia, Colombia

Title: Aspects of controlled-release dosage forms in veterinary medicine with emphasis on GRDF
Eran Lavy, Hebrew University of Jerusalem, Israel

For Magnus Group Conferences Reviews:

Magnus Group Hematology Conferences Reviews | Magnus Conferences Reviews

2nd Edition of International Conference on Oncology and Radiology 2018 Report:

Magnus Group Successfully completed “2nd Edition of  International Conference on Oncology and Radiology which was held in Rome, Italy, during September 17-19, 2018.

Cancer Conference 2018 witnessed an amalgamation of outstanding speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Oncology and Radiology. The extremely well-known conference hosted by Magnus Group was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing diverse countries around the world.

Recommended Hematology Conferences | Blood Disorders Conference | Hematology Conferences | Blood Disorders Events | Blood Diseases Congress | Hematology Meetings | Hematology Congresses | Hematology Events | Hematology Conferences 2023 | Blood Disorders Conference 2023 | Hematology Congresses 2023 | Hematology Meetings 2023 | Blood Disorders Congress 2023 | Blood Disorders Events | Hematology Meeting | Hematology Conference | Hematology Meeting 2023

For ICOR 2018 Final ProgramClick Here

For ICOR 2018 Abstract Book: Click Here

Magnus Group is privileged to thank the Organizing Committee Members and Keynote Speakers for making their contributions in the form of very informative presentation.

Lucio Miele, Louisiana State University Health Sciences Center, USA
Elizabeth Franzmann, Vigilant Biosciences, USA
Rossana Berardi, Universita Politecnica delle Marche, Italy
Tamara Lah Turnsek, National Institute of Biology, Slovenia
Jozef Sabol, Department of Crisia Management, PACR, Czech Republic

ICOR 2018 Speaker Line Up:

Title: The interface of breast cancer and diabetes: Practical options to manage weight gain in women at high-risk for breast cancer
Victoria Seewaldt, City of Hope Comprehensive Cancer Center, USA

Title: Prevalence of HPV and HPV-related dysplasia in elderly women
Annika Lindstrom, CKF Dalarna, Uppsala University, Sweden

Title: Electrochemotherapy as a new approach on pancreatic cancer and on liver metastases
Francesco Izzo, National Cancer Institute of Naples, Italy

Title: Monitoring of antifungal therapy using 18FDG-PET/CT in patients with acute leukemia: 2 case reports
Jerome Paillassa, Centre Hospitalier Universitaire d'Angers, France

Title: Stereotatic body radiotherapy for liver metastases: A Single-Institute experience in Taiwan
Yaoru Huang, Taipei Medical University Hospital, Taiwan

Title: The role of selective intraaterial and intravitreal chemotherapy in organ-preserving treatment of the children with an intraocular retinoblastoma
Igor Pogrebniakov, SRI of clinical and experimental radiology of N.N.Blokhin CRC, Russian Federation

Title: CXCR4 and RANK as a predictor bone metastasis in breast cancer
Erwin Danil Yulian, University of Indonesia, Indonesia

Title: Role of 9-Fluorenone in regulation of cancer stem cell properties through direct targeting of a mesenchymal stem cell’s marker TAZ
Surajit Pathak, Chettinad Academy of Research and Education, India

Title: Molecular markers in low-grade glioma: Correlative analysis of NRG trials
Joshua D. Palmer, Ohio State University Wexner Medical Center, United States

Title: Lung cancer screening: Simplifying the shared decision making process
Mark S. Parker, VCU Medical Center, USA

Title: Gemcitabine-based neoadjuvant treatments in borderline resectable pancreatic ductal adenocarcinoma (BR-PDAC): A systematic review and meta-analysis ofindividual patient data
Francesco Giovinazzo, University Hospital of Southampton NHS Foundation Trust, UK

Title: A novel therapeutic target in multistage tumorigenesis
Myron R. Szewczuk, Queen’s University, Canada

Title: Neoadjuvant treatment in pancreatic cancer: How far are we from standardization?
Giulia Zumbo, Southampton General Hospital, Uk

Title: Characterization of tumorspheres generated from primary mesenchymal colon cancer cells for the study of colorectal cancer progression
Marina De Rosa, University of Naples Federico II, Italy

Title: Enhancing the drug load of PSMA-specific targeted drugs
Jose Carlos dos Santos, Universitatsklinikum Heidelberg, Germany

Title: Influence of family income and medical insurance coverage on health-related quality of life and optimism in cancer patients at a Hong Kong private hospital: A cross-sectional study
Chiu Sai Yiu Richard, Hong Kong Baptist Hospital, Hong Kong

Title: Principles of radiotherapy in head and neck cancers
Neeraj Jain, Sri Guru Ram Das University of Health Science, India

Title: Nanobodies and OncoFinder: A combined approach for identification of molecular changes in glioblastoma
Ivana Jovcevska, University of Ljubljana, Slovenia

Title: Wwox expression inhibits growth of irradiated cancer cells in vivo
Bahadir Batar, Namik Kemal University School of Medicine, Turkey

Title: Human cytomegalovirus infection in febrile patients with hematological malignancies at Uganda cancer institute
Ocung guido, Makerere University, Uganda

Title: Quality assurance of VMAT head and neck cancer treatment using PRESAGE® dosimeter
Jalil Ur Rehman, Baluchistan University of Information Technology Engineering , Managements and Science, Pakistan


ICOR 2018 Poster Presenters:

Title: Mullerian inhibiting substance (MIS)/anti-Mullerian hormone (AMH) induces the apoptosis in endometrial cancer cells
Joo Hee Yoon, The Catholic University of Korea, Korea, Republic of

Title: Potential chemotherapeutic agent haemanthamine affects the anticancer effect of histone deacetylase inhibitor in ovarian cancer cells
Martina Seifrtova, Charles University, Czech Republic

Title: The human papillomavirus E6 protein targets apoptosis-inducing factor (AIF) for degradation
Masaru Shimada, Yokohama City University, Japan

Title: Development of novel radioprotective agents based on small molecule inhibitors
Radim Havelek, Charles University, Czech Republic

Title: Exosomal gastrokine 1 is a theragnostic target for gastric cancer
Jung Hwan Yoon, The Catholic University, Korea, Republic of

Title: Immunocytochemical negativity of HPV L1 proteins in ASCUS or LSIL can predict higher grade CIN 
Miyoung Park, The Catholic University of Korea, Korea, Republic of

Title: Brain connectivity changes after transient stroke: Using fMRI and DTI
Chae Ri Park, Asan medical center (AMC), Korea, Republic of

Title: Radio-sensitizing effect of low-dose acetaminophen
Youn Kyoung Jeong, Korea Institute of Radiological & Medical Sciences, Korea, Republic of

Title: Development of novel radioprotective agents based on small molecule inhibitors
Jan Marek, Faculty Hospital Hradec Kralove, Czech Republic

Magnus Group would like to  thank all the participants for their wonderful involvement towards the event which helped us for successful execution of this event.

Recommended Hematology Conferences | Blood Disorders Conference | Hematology Conferences | Blood Disorders Events | Blood Diseases Congress | Hematology Meetings | Hematology Congresses | Hematology Events | Hematology Conferences 2023 | Blood Disorders Conference 2023 | Hematology Congresses 2023 | Hematology Meetings 2023 | Blood Disorders Congress 2023 | Blood Disorders Events | Hematology Meeting | Hematology Conference | Hematology Meeting 2023

Mark your calendars for the upcoming Hematology 2023 conference; We are hoping to see you soon!

For Magnus Group Conferences Reviews:

Magnus Group Hematology Conferences Reviews | Magnus Conferences Reviews

Conference Schedule

08:00-09:00

Registration

09:00-09:30

Opening Ceremony and Introduction

09:30-10:30

Keynote Session I

10:30-11:00

Refreshment Break

11:00-12:30

Keynote Session II

12:30-13:30

Lunch

13:30-15:00

Break Out Session I

15:00-15:30

Refreshment Break

15:30-18:00

Break Out Session II

09:00-10:30

Keynote Session III

10:30-11:00

Refreshment Break

11:00-12:30

Break Out Session III

12:30-13:30

Lunch

13:30 15:00

Poster Presentations

15:00-15:30

Refreshment Break

15:30-18:00

Break Out Session IV

09:00-10:30

Keynote Session IV

10:30-11:00

Refreshment Break

11:00-12:30

Break Out Session V

12:30-13:30

Lunch

13:30 15:00

Break Out Session VI

15:00-15:30

End Note Session and Closing Ceremony

Watch Past Conference Review

Photo Gallery (Our Past Events)

Testimonials

Watsapp